The Qcrb inhibitors TB47 and telacebec do not potentiate the activity of clofazimine in mycobacterium abscessus
The antituberculosis drug telacebec is ineffective against Mycobacterium abscessus. A recent study suggested that TB47, a telacebec analogue, potentiated the efficacy of clofazimine against M. abscessus. Here, we report that TB47 not only is ineffective against M. abscessus in vitro but also does no...
Saved in:
Main Authors: | Sorayah, Ria, Moraski, Garret C., Barkan, Daniel, Pethe, Kevin |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Article |
Language: | English |
Published: |
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/153678 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Naturally-occurring polymorphisms in QcrB are responsible for resistance to Telacebec in Mycobacterium abscessus
by: Sorayah, Ria, et al.
Published: (2021) -
Sensitivity of mycobacterium leprae to telacebec
by: Lahiri, Ramanuj, et al.
Published: (2022) -
The addition of avibactam renders piperacillin an effective treatment for Mycobacterium abscessus infection in an in vivo model
by: Meir, M., et al.
Published: (2021) -
An anti-mycobacterial conjugated oligoelectrolyte effective against Mycobacterium abscessus
by: Zhang, Kaixi, et al.
Published: (2024) -
Single cell analysis of drug susceptibility of mycobacterium abscessus during macrophage infection
by: Brzostek, J., et al.
Published: (2021)